LAM THI NGOC TRINH

21DH717245

REFERNCES

1) Adams, J., Khan, H. T. A., Raeside, R., & White, D. (2007). Research Methods
for Graduate Business and Social Science Students. Sage Publications Ltd.,
London.
2) Jiang, K. (2021). Review on Binge Eating Disorder: Theories, Influencing
Factors and Treatments. Advances in Social Science, Education and Humanities
Research, 561, 574-578.
3) Mitchell, J. E., Devlin, M. J., de Zwaan, M., Crow, S. J., & Peterson, C. (2007).
Binge-Eating Disorder: Clinical Foundations and Treatment. Guilford Press.
4) Mohajan, D., & Mohajan, H. K. (2023). Bulimia Nervosa: A Psychiatric
Problem of Disorder. Innovation in Science and Technology, 2(3), 26-32.
5) Mohajan, D., & Mohajan, H. K. (2023). Metformin: An Oral Anti-
hyperglycaemic Agent for the Treatment of Type 2 diabetes. Unpublished
Manuscript.
6) Moskovich AA, Dmitrieva NO, Babyak MA, et al. Real-time predictors and
consequences of binge eating among adults with type 1 diabetes. Journal of
Eating Disorders. 2019;7:7. doi:10.1186/s40337-019-0237-3
7) Pearl, R. L, White, M. A., & Grilo, C. M. (2014). Overvaluation of Shape and
Weight as a Mediator between Self-Esteem and Weight Bias Internalization
among Patients with Binge Eating Disorder. Eating Behaviors, 15(2), 259-261.
8) Presby RE, Rotolo RA, Yang J-H, Correa M, Salamone JD. Lisdexamfetamine
suppresses instrumental and consummatory behaviors supported by foods with
varying degrees of palatability: exploration of a binge-like eating model. Pharm
Biochem Behav. 2020;189:172851.
9) Raevuori A, Suokas J, Haukka J, et al. Highly increased risk of type 2 diabetes
in patients with binge eating disorder and bulimia nervosa. International
Journal of Eating Disorders. 2015;48(6):555–562. doi:10.1002/eat.22334
10) Schneider E, Higgs S, Dourish CT. Lisdexamfetamine and binge eating disorder:
a systematic review and meta-analysis of the preclinical and clinical data with a
focus on mechanism of drug action in treating the disorder. Eur
Neuropsychopharmacol. 2021;53:49–78.
11) Sheehan, D. V., & Herman, B. K. (2015). The Psychological and Medical
Factors Associated with Untreated Binge Eating Disorder. Primary Care
Companion for CNS Disorders, 17(2), 10.4088/PCC.14r01732.
12) Swanson SA, Crow SJ, Le Grange D, Swendsen J, Merikangas KR. Prevalence
and correlates of eating disorders in adolescents. Results from the National
Comorbidity Survey Replication Adolescent Supplement. Archives of General
Psychiatry. 2011;68(7):714–723. doi:10.1001/archgenpsychiatry.2011.22
13) Thomas JM, Higgs S, Dourish CT. Test-retest reliability and effects of repeated
testing and satiety on performance of an emotional test battery. J Clin Exp
Neuropsychol. 2016;38:416–33.
14) Wassenaar, E., Friedman, J., & Mehler, P. S. (2019). Medical Complications of
Binge Eating Disorder. Psychiatric Clinics of North America, 42(2), 275-286.
15) Yeomans MR, Gray RW. Effects of naltrexone on food intake and changes in
subjective appetite during eating: evidence for opioid involvement in the
appetizer effect. Physiol Behav. 1997;62:15–21. doi: 10.1016/s0031-
9384(97)00101-7.
16) Zayas, L. V. et al. (2018). Gender Differences in Eating Disorder
Psychopathology across DSM5 Severity Categories of Anorexia Nervosa and
Bulimia Nervosa. International Journal of Eating Disorders, 51(9), 1098-1102.